盆底重建联合盆底康复治疗仪在女性盆底功能障碍性疾病中的临床应用研究

发布时间：2018-07-05 06:14

  本文选题：盆底功能障碍 + 盆底重建　； 参考：《河北医药》2016年02期

【摘要】：目的探讨盆底重建联合盆底康复治疗仪在女性盆底功能障碍性疾病中的临床应用价值。方法 125例盆底功能障碍性疾病患者随机分为对照组(n=62)和治疗组(n=63)。对照组采用腹腔镜下高位骶韧带悬吊术,治疗组:采用盆底重建手术,使用Gynecare Prolift骨盆底修复系统。2组患者手术1个月后,采用盆底康复治疗仪Phenix USB4进行治疗。观察2组患者手术时间、术中出血量、排气时间和尿管留置时间、分度指示点测量和肌电活动、肌力情况,并对患者进行随访6个月,观察2组患者盆底功能障碍问卷评分(PFDI-20)和复发情况。结果治疗组患者手术时间、出血量、排气时间和尿管留置时间与对照组比较,差异有统计学意义(P0.05)。2组治疗后肌电水平与治疗前比较显著提高(P0.05),治疗组治疗后肌电水平高于对照组,但差异无统计学意义(P0.05)。治疗组治疗后分度指示点与对照组比较,差异有统计学意义(P0.05)。2组治疗后肌力均优于治疗前(P0.05)。2组治疗后PFDI-20评分与治疗前比较显著降低,差异有统计学意义(P0.05),治疗组治疗后PFDI-20评分和复发率低于对照组,差异有统计学意义(P0.05)。结论盆底重建对Ⅲ、Ⅳ度脱垂患者有良好的治疗效果,可以缩短手术时间、减少术中出血量,患者恢复时间短,复发率低,联合盆底康复治疗仪有助于患者术后盆底组织肌力恢复。
[Abstract]:Objective to evaluate the clinical value of pelvic floor reconstruction combined with pelvic floor rehabilitation therapy in female patients with pelvic floor dysfunction. Methods 125 patients with pelvic floor dysfunction were randomly divided into control group (n = 62) and treatment group (n = 63). The control group was treated with laparoscopic high sacral ligament suspension, and the treatment group was treated with pelvic floor reconstruction, Gynecare Prolift pelvic floor repair system and Phenix USB4. The operative time, blood loss, exhaust time and indwelling time of urinary catheter were observed in two groups. The measurement of index points, myoelectric activity and muscle strength were observed. The patients were followed up for 6 months. The pelvic floor dysfunction scale (PFDI-20) and recurrence were observed. Results the operative time, bleeding volume, exhaust time and urinary catheter retention time in the treatment group were compared with those in the control group. The difference was statistically significant (P0.05). 2 after treatment, the level of EMG in the treatment group was significantly higher than that in the control group (P0.05), but the difference was not statistically significant (P0.05). Compared with the control group, there was a significant difference between the treatment group and the control group (P0.05). 2. The muscle strength of the treatment group was significantly higher than that of the pre-treatment group (P0.05). The PFDI-20 score of the treatment group was significantly lower than that of the pre-treatment group. The difference was statistically significant (P0.05). The PFDI-20 score and recurrence rate in the treatment group were lower than those in the control group (P0.05). Conclusion pelvic floor reconstruction has a good therapeutic effect on patients with grade 鈪，

本文编号：2099255